Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
According to Baxter's latest financial reports the company's total debt is ยฃ10.09 Billion. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2024-12-31 | ยฃ10.71 B | -3.26% |
2023-12-31 | ยฃ11.07 B | -22.1% |
2022-12-31 | ยฃ14.21 B | 4.83% |
2021-12-31 | ยฃ13.56 B | 171.74% |
2020-12-31 | ยฃ4.99 B | 9.81% |
2019-12-31 | ยฃ4.54 B | 65.58% |
2018-12-31 | ยฃ2.74 B | 5.65% |
2017-12-31 | ยฃ2.59 B | 15.26% |
2016-12-31 | ยฃ2.25 B | -48.65% |
2015-12-31 | ยฃ4.39 B | -24.29% |
2014-12-31 | ยฃ5.79 B | 4.36% |
2013-12-31 | ยฃ5.55 B | 51.46% |
2012-12-31 | ยฃ3.66 B | 9.77% |
2011-12-31 | ยฃ3.34 B | 17.61% |
2010-12-31 | ยฃ2.84 B | 10.79% |
2009-12-31 | ยฃ2.56 B | 0.1% |
2008-12-31 | ยฃ2.56 B | 64.82% |
2007-12-31 | ยฃ1.55 B | 8.74% |
2006-12-31 | ยฃ1.42 B | -26.12% |
2005-12-31 | ยฃ1.93 B | -13.46% |
2004-12-31 | ยฃ2.23 B | -12.53% |
2003-12-31 | ยฃ2.55 B | -11.77% |
2002-12-31 | ยฃ2.89 B | 56.39% |
2001-12-31 | ยฃ1.85 B | 17.2% |
2000-12-31 | ยฃ1.58 B | -10.54% |
1999-12-31 | ยฃ1.76 B | -12.71% |
1998-12-31 | ยฃ2.02 B | 19.69% |
1997-12-31 | ยฃ1.69 B | 41.93% |
1996-12-31 | ยฃ1.19 B |